Cancer Patients Have a Higher Risk Regarding COVID-19–and Vice Versa?
The world is currently suffering from a pandemic which has claimed the lives of over 230,000 people to date. The responsible virus is called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and causes the coronavirus disease 2019 (COVID-19), which is mainly characterized by fever, cough...
Main Authors: | Franz Geisslinger, Angelika M. Vollmar, Karin Bartel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/7/143 |
Similar Items
-
Deciphering the Relationship between SARS-CoV-2 and Cancer
by: Michele Costanzo, et al.
Published: (2023-04-01) -
SARS-CoV-2 and probable lung cancer risk
by: Sajad Khiali, et al.
Published: (2022-05-01) -
Role of Leptin in Inflammation and Vice Versa
by: Antonio Pérez-Pérez, et al.
Published: (2020-08-01) -
Vasculitis and COVID-19: what do we have to know?
by: Antonio Tamburello, et al.
Published: (2020-12-01) -
Immunotherapy and Gene Therapy for Oncoviruses Infections: A Review
by: Nathália Alves Araújo de Almeida, et al.
Published: (2021-05-01)